ARMI | BioFabUSA will attend SynBioBeta 2026, the leading synthetic biology conference, taking place May 4–7, 2026, in San Jose, CA. With a focus on the convergence of synthetic biology and advanced manufacturing, SynBioBeta provides a powerful platform for ARMI to highlight its innovations in regenerative manufacturing—and features Dean Kamen among key speakers.
SynBioBeta 2026 convenes global leaders in synthetic biology, biotechnology, and bioengineering to explore new frontiers in science and business. As the field continues to evolve, ARMI brings its regenerative manufacturing expertise to the conversation, connecting scalable technologies with the tools and techniques of synthetic biology.
At SynBioBeta, ARMI will:
Dean Kamen, founder of ARMI and an icon in biomedical innovation, will take the stage to share visionary insights on the role of manufacturing in enabling the synthetic biology revolution. His remarks will emphasize the importance of infrastructure, collaboration, and real-world implementation.
Through this engagement, ARMI reinforces its role as a catalyst for integrating synthetic biology with advanced biomanufacturing—helping bridge the gap between scientific discovery and patient impact.